Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jun;9(3):1475-1478.
doi: 10.21037/tau-20-832.

Highlighting the road towards new disease-specific comorbidity indices

Paolo Dell'Oglio  1 , Elio Mazzone  2 , Zhe Tian  3 , Pierre I Karakiewicz  3   4
Affiliations
Comment

Highlighting the road towards new disease-specific comorbidity indices

Paolo Dell'Oglio et al. Transl Androl Urol. 2020 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have completed the ICMJE uniform disclosure from (available at http://dx.doi.org/10.21037/tau-20-832). The authors have no conflicts of interests to declare.

Figures

Figure 1
Figure 1
Risk calculator based on the combination of 6 individual comorbid conditions and 2 individual bladder cancer manifestations that allows individual estimate of 90-day mortality after radical cystectomy (3).
See this image and copyright information in PMC

Comment on

References

    1. Regmi SK, Konety BR. Studying the impact of comorbidity on post radical cystectomy survival: have we come a full circle? Transl Androl Urol 2019;8:S314-7. 10.21037/tau.2019.06.06 - DOI - PMC - PubMed
    1. Fonteyne V, Rammant E, Decaestecker K. Predicting perioperative mortality after radical cystectomy: comorbidity assessment tools are only part of the puzzle. Transl Androl Urol 2019;8:781-4. 10.21037/tau.2019.07.06 - DOI - PMC - PubMed
    1. Dell'Oglio P, Tian Z, Leyh-Bannurah SR, et al. Development of a New Comorbidity Assessment Tool for Specific Prediction of Perioperative Mortality in Contemporary Patients Treated with Radical Cystectomy. Ann Surg Oncol 2019;26:1942-9. 10.1245/s10434-019-07313-y - DOI - PubMed
    1. Williams SB, Kamat AM, Chamie K, et al. Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients. Eur Urol Oncol 2018;1:91-100. 10.1016/j.euo.2018.03.005 - DOI - PMC - PubMed
    1. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83. 10.1016/0021-9681(87)90171-8 - DOI - PubMed